lesopitron has been researched along with Serotonin Syndrome in 1 studies
*Serotonin Syndrome: An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camarasa, J; Escubedo, E; Farré, A; Fisas, MA | 1 |
1 other study(ies) available for lesopitron and Serotonin Syndrome
| Article | Year |
|---|---|
Effects of lesopitron on the central nervous system arising from its interaction with 5-HT1A receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Catalepsy; Central Nervous System; Central Nervous System Depressants; Drug Interactions; Female; Hippocampus; Hypothermia; In Vitro Techniques; Ligands; Male; Mice; Paroxetine; Piperazines; Pyrimidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Serotonin Syndrome; Species Specificity | 2004 |